Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Stroke

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 59 articles:
HTML format
Text format



Single Articles


    December 2018

  1. Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial.
    Lancet. 2018 Dec 4. pii: S0140-6736(18)32823.
    PubMed     Text format     Abstract available


    October 2018
  2. CHILAMKURTHY S, Ghosh R, Tanamala S, Biviji M, et al
    Deep learning algorithms for detection of critical findings in head CT scans: a retrospective study.
    Lancet. 2018 Oct 11. pii: S0140-6736(18)31645.
    PubMed     Text format     Abstract available


  3. ZERNA C, Thomalla G, Campbell BCV, Rha JH, et al
    Current practice and future directions in the diagnosis and acute treatment of ischaemic stroke.
    Lancet. 2018;392:1247-1256.
    PubMed     Text format     Abstract available


  4. PANDIAN JD, Gall SL, Kate MP, Silva GS, et al
    Prevention of stroke: a global perspective.
    Lancet. 2018;392:1269-1278.
    PubMed     Text format     Abstract available


  5. THE LANCET
    21st century management and prevention of stroke.
    Lancet. 2018;392:1167.
    PubMed     Text format    


    September 2018
  6. BHATT DL
    Aspirin-still the GLOBAL LEADER in antiplatelet therapy.
    Lancet. 2018;392:896-897.
    PubMed     Text format    


    August 2018
  7. VALGIMIGLI M, Frigoli E, Leonardi S, Vranckx P, et al
    Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial.
    Lancet. 2018 Aug 24. pii: S0140-6736(18)31714.
    PubMed     Text format     Abstract available


  8. GAZIANO JM, Brotons C, Coppolecchia R, Cricelli C, et al
    Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial.
    Lancet. 2018 Aug 24. pii: S0140-6736(18)31924.
    PubMed     Text format     Abstract available


  9. ROTHWELL PM, Cook NR, Gaziano JM, Price JF, et al
    Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials.
    Lancet. 2018;392:387-399.
    PubMed     Text format     Abstract available


    June 2018
  10. PATEL T, Tesfaldet B, Chowdhury I, Kettermann A, et al
    Endpoints in diabetes cardiovascular outcome trials.
    Lancet. 2018;391:2412.
    PubMed     Text format    


  11. DEVEREAUX PJ, Duceppe E, Guyatt G, Tandon V, et al
    Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial.
    Lancet. 2018;391:2325-2334.
    PubMed     Text format     Abstract available


    May 2018
  12. LANGHORNE P, O'Donnell MJ, Chin SL, Zhang H, et al
    Practice patterns and outcomes after stroke across countries at different economic levels (INTERSTROKE): an international observational study.
    Lancet. 2018;391:2019-2027.
    PubMed     Text format     Abstract available


  13. BRAININ M
    Stroke units around the world: the success story continues.
    Lancet. 2018;391:1970-1971.
    PubMed     Text format    


  14. SPRIGG N, Flaherty K, Appleton JP, Salman RA, et al
    Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial.
    Lancet. 2018 May 15. pii: S0140-6736(18)31033.
    PubMed     Text format     Abstract available


    February 2018
  15. ABUKARESH A, Al-Abadlah R, Bottcher B, El-Essi K, et al
    Ischaemic stroke management at Al-Shifa Hospital in the Gaza Strip: a clinical audit.
    Lancet. 2018;391 Suppl 2:S7.
    PubMed     Text format     Abstract available


  16. ALKHATIB MN, Abd-Alghafoor T, Elmassry A, Albarqouni L, et al
    Management of acute ischaemic stroke at Nasser Hospital, Gaza Strip: a clinical audit.
    Lancet. 2018;391 Suppl 2:S28.
    PubMed     Text format     Abstract available


  17. THE LANCET
    Stroke-acting FAST at all ages.
    Lancet. 2018;391:514.
    PubMed     Text format    


    January 2018
  18. ANAND SS, Bosch J, Eikelboom JW, Connolly SJ, et al
    Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.
    Lancet. 2018;391:219-229.
    PubMed     Text format     Abstract available


    December 2017
  19. AMARENCO P
    Learning from TARDIS: time for more focused trials in stroke prevention.
    Lancet. 2017 Dec 20. pii: S0140-6736(17)33309.
    PubMed     Text format    


  20. BATH PM, Woodhouse LJ, Appleton JP, Beridze M, et al
    Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial.
    Lancet. 2017 Dec 20. pii: S0140-6736(17)32849.
    PubMed     Text format     Abstract available


    November 2017
  21. CONNOLLY SJ, Eikelboom JW, Bosch J, Dagenais G, et al
    Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial.
    Lancet. 2017 Nov 10. pii: S0140-6736(17)32458.
    PubMed     Text format     Abstract available


    October 2017
  22. WOOD D, Eisele JL
    A global coalition for the fight against heart disease and stroke.
    Lancet. 2017 Oct 16. pii: S0140-6736(17)32676.
    PubMed     Text format    


    August 2017
  23. SIBBING D, Aradi D, Jacobshagen C, Gross L, et al
    Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial.
    Lancet. 2017 Aug 25. pii: S0140-6736(17)32155.
    PubMed     Text format     Abstract available


  24. VINEREANU D, Lopes RD, Bahit MC, Xavier D, et al
    A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial.
    Lancet. 2017 Aug 25. pii: S0140-6736(17)32165.
    PubMed     Text format     Abstract available


  25. JINATONGTHAI P, Kongwatcharapong J, Foo CY, Phrommintikul A, et al
    Comparative efficacy and safety of reperfusion therapy with fibrinolytic agents in patients with ST-segment elevation myocardial infarction: a systematic review and network meta-analysis.
    Lancet. 2017;390:747-759.
    PubMed     Text format     Abstract available


    July 2017
  26. SAKAMOTO R, Higuchi A, Tsuda K, Tanimoto T, et al
    Intensive speech and language therapy after stroke.
    Lancet. 2017;390:228.
    PubMed     Text format    


  27. BREITENSTEIN C, Martus P, Willmes K, Ziegler W, et al
    Intensive speech and language therapy after stroke - Authors' reply.
    Lancet. 2017;390:228-229.
    PubMed     Text format    


  28. WARE RE, de Montalembert M, Tshilolo L, Abboud MR, et al
    Sickle cell disease.
    Lancet. 2017;390:311-323.
    PubMed     Text format     Abstract available


    June 2017

  29. Family-led rehabilitation after stroke in India (ATTEND): a randomised controlled trial.
    Lancet. 2017 Jun 27. pii: S0140-6736(17)31447.
    PubMed     Text format     Abstract available


  30. LI L, Geraghty OC, Mehta Z, Rothwell PM, et al
    Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study.
    Lancet. 2017 Jun 13. pii: S0140-6736(17)30770.
    PubMed     Text format     Abstract available


    April 2017
  31. KIRCHHOF P
    The future of atrial fibrillation management: integrated care and stratified therapy.
    Lancet. 2017 Apr 28. pii: S0140-6736(17)31072.
    PubMed     Text format     Abstract available


  32. HACHINSKI V
    Stoop to conquer: preventing stroke and dementia together.
    Lancet. 2017;389:1518.
    PubMed     Text format    


    March 2017
  33. HEALEY JS, Oldgren J
    Risk of mortality and stroke after atrial fibrillation - Authors' reply.
    Lancet. 2017;389:907.
    PubMed     Text format    


  34. HUO Z
    Risk of mortality and stroke after atrial fibrillation.
    Lancet. 2017;389:907.
    PubMed     Text format    


  35. MIHAS C, Mariolis A, Letsas KP, Kantzanou M, et al
    Risk of mortality and stroke after atrial fibrillation.
    Lancet. 2017;389:906.
    PubMed     Text format    


    February 2017
  36. BREITENSTEIN C, Grewe T, Floel A, Ziegler W, et al
    Intensive speech and language therapy in patients with chronic aphasia after stroke: a randomised, open-label, blinded-endpoint, controlled trial in a health-care setting.
    Lancet. 2017 Feb 27. pii: S0140-6736(17)30067.
    PubMed     Text format     Abstract available


    January 2017
  37. HANLEY DF, Lane K, McBee N, Ziai W, et al
    Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial.
    Lancet. 2017 Jan 9. pii: S0140-6736(16)32410.
    PubMed     Text format     Abstract available


  38. RABINSTEIN AA
    Intracerebral haemorrhage: no good treatment but treatment helps.
    Lancet. 2017 Jan 9. pii: S0140-6736(17)30002.
    PubMed     Text format    


  39. O'DONNELL M, Yusuf S
    The INTERSTROKE study on risk factors for stroke - Authors' reply.
    Lancet. 2017;389:36.
    PubMed     Text format    


  40. ZENG X, Deng A, Ding Y
    The INTERSTROKE study on risk factors for stroke.
    Lancet. 2017;389:35.
    PubMed     Text format    


    November 2016
  41. COLLINS R, Reith C, Emberson J, Armitage J, et al
    Interpretation of the evidence for the efficacy and safety of statin therapy.
    Lancet. 2016;388:2532-2561.
    PubMed     Text format     Abstract available


    October 2016
  42. MAKIKALLIO T, Holm NR, Lindsay M, Spence MS, et al
    Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial.
    Lancet. 2016 Oct 28. pii: S0140-6736(16)32052.
    PubMed     Text format     Abstract available


  43. CHARIDIMOU A
    The ABC risk score for patients with atrial fibrillation.
    Lancet. 2016;388:1979.
    PubMed     Text format    


  44. PROVIDENCIA R, Lambiase PD
    The ABC risk score for patients with atrial fibrillation.
    Lancet. 2016;388:1979-1980.
    PubMed     Text format    


  45. GUAN WJ, Zheng XY, Chung KF, Zhong NS, et al
    Impact of air pollution on the burden of chronic respiratory diseases in China: time for urgent action.
    Lancet. 2016;388:1939-1951.
    PubMed     Text format     Abstract available


  46. SHAKIR R, Davis S, Norrving B, Grisold W, et al
    Revising the ICD: stroke is a brain disease.
    Lancet. 2016 Oct 14. pii: S0140-6736(16)31850.
    PubMed     Text format    


    September 2016
  47. HANKEY GJ
    Stroke.
    Lancet. 2016 Sep 13. pii: S0140-6736(16)30962.
    PubMed     Text format     Abstract available


    August 2016
  48. GOETTE A, Merino JL, Ezekowitz MD, Zamoryakhin D, et al
    Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial.
    Lancet. 2016 Aug 26. pii: S0140-6736(16)31474.
    PubMed     Text format     Abstract available


  49. VIDAL-PETIOT E, Ford I, Greenlaw N, Ferrari R, et al
    Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study.
    Lancet. 2016 Aug 26. pii: S0140-6736(16)31326.
    PubMed     Text format     Abstract available


  50. BAGOT KL, Cadilhac DA, Hand PJ, Vu M, et al
    Telemedicine expedites access to optimal acute stroke care.
    Lancet. 2016;388:757-758.
    PubMed     Text format    


  51. THE LANCET
    Atrial fibrillation and stroke: unrecognised and undertreated.
    Lancet. 2016;388:731.
    PubMed     Text format    


  52. PICCINI JP, Fauchier L
    Rhythm control in atrial fibrillation.
    Lancet. 2016;388:829-840.
    PubMed     Text format     Abstract available


  53. FREEDMAN B, Potpara TS, Lip GY
    Stroke prevention in atrial fibrillation.
    Lancet. 2016;388:806-817.
    PubMed     Text format     Abstract available


  54. HEALEY JS, Oldgren J, Ezekowitz M, Zhu J, et al
    Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study.
    Lancet. 2016 Aug 8. pii: S0140-6736(16)30968.
    PubMed     Text format     Abstract available


  55. BORLONGAN CV
    Age of PISCES: stem-cell clinical trials in stroke.
    Lancet. 2016 Aug 3. pii: S0140-6736(16)31259.
    PubMed     Text format    


  56. KALLADKA D, Sinden J, Pollock K, Haig C, et al
    Human neural stem cells in patients with chronic ischaemic stroke (PISCES): a phase 1, first-in-man study.
    Lancet. 2016 Aug 3. pii: S0140-6736(16)30513.
    PubMed     Text format     Abstract available


    July 2016
  57. SNYDER A
    Philip Majerus.
    Lancet. 2016;388:458.
    PubMed     Text format    


  58. FEIGIN VL, Krishnamurthi R
    Stroke is largely preventable across the globe: where to next?
    Lancet. 2016 Jul 15. pii: S0140-6736(16)30679.
    PubMed     Text format    


  59. O'DONNELL MJ, Chin SL, Rangarajan S, Xavier D, et al
    Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study.
    Lancet. 2016 Jul 15. pii: S0140-6736(16)30506.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Stroke is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: